Network origin in Diana M. Hablitz first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
TransMolecular, Inc.
 TransMolecular, Inc. BiotechnologyHealth Technology TransMolecular is an oncology-focused biotechnology company committed to developing novel proprietary drugs to diagnose and treat human diseases using a novel tumor targeting platform called TM601. Their development program to date has explored the therapeutic use of TM601 in cancer and neovascular diseases of the eye, and their lead candidate, TM601 conjugated to the radioactive isotope 131I, has a Special Protocol Agreement (SPA) with the FDA for a pivotal, Phase 3 trial in newly diagnosed glioblastoma multiforme (glioma). TM601 has unique properties of highly specific tumor cell binding and internalization while not affecting normal cells, targeting both primary disease sites and metastases. The interaction of TM601 with a specific protein known to be over-expressed on the surface of tumor cells and vascular endothelium is implicated in these tumor-specific binding properties. Conjugated to an anti-cancer radioactive isotope, TM601 has been successful in human and animal models in demonstrating selective targeting and uptake in a number of different tumor types, and in tumor locations within the central nervous system (CNS) and peripherally. Expanded research confirms that TM601 can deliver a variety of conjugates, creating potential for development of a wide array of anti-cancer therapies. In addition to the tumor targeting capability of TM601, a number of studies have also revealed that TM0601 exerts robust anti-angiogenic effects on vessels associated with neovascular disease. Pursuing this anti-angiogenic potential further, They have also determined the utility of TM601 in animal ophthalmic models. The company is leveraging its platform in strategic collaborations with partners seeking to expand product pipelines, extend product life-cycles for existing anti-tumor compounds, or optimize therapeutic activity of marginally effective or restrictively toxic drugs.
14
| Extinct | Biotechnology | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Diana M. Hablitz via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
| GENVEC INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| PREMD INC. | Medical Specialties | Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Bradford | College/University | Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
TVM Capital GmbH
 TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Chairman | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Tullis Health Investors, Inc.
 Tullis Health Investors, Inc. Investment ManagersFinance Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Doctorate Degree | |
| Pine Manor College | College/University | Undergraduate Degree | |
PF Consumer Healthcare Canada ULC
 PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member | |
The Royal Bank of Scotland International Ltd.
 The Royal Bank of Scotland International Ltd. Major BanksFinance The Royal Bank of Scotland International Ltd. provides personal and corporate banking services. It offers offshore banking, personal banking, and corporate banking. The company was founded in 1966 and is headquartered in St. Helier, Jersey. | Major Banks | Director of Finance/CFO | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
| Université Toulouse III - Paul Sabatier | College/University | Undergraduate Degree | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
| OMNIMMUNE HOLDINGS, INC. | Biotechnology | Director/Board Member | |
DiscoveryBioMed, Inc.
 DiscoveryBioMed, Inc. BiotechnologyHealth Technology DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL. | Biotechnology | Director/Board Member | |
| REZOLUTE, INC. | Pharmaceuticals: Major | General Counsel | |
| Harvard Business School | College/University | Masters Business Admin | |
SpePharm AG
 SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Director/Board Member | |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chairman | |
Amytrx Therapeutics, Inc.
 Amytrx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amytrx Therapeutics, Inc. developed biological medicines. The company was headquartered in Nashville, TN. | Pharmaceuticals: Major | Founder | |
| TME PHARMA N.V. | Biotechnology | Chairman | |
AL-S Pharma AG
 AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chairman | |
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member | |
| Zeneca AGro Gmbh | Sales & Marketing | ||
TVM Life Science Management GmbH
 TVM Life Science Management GmbH Miscellaneous Commercial ServicesCommercial Services Part of TVM Capital GmbH, TVM Life Science Management GmbH provides management services. The company is based in Munich, Germany. The CEO of the German company is Stefan Fischer. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
| United States | 25 |
| Germany | 14 |
| United Kingdom | 5 |
| Switzerland | 4 |
| Canada | 3 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 5 |
| Health Services | 4 |
Operational
| Director/Board Member | 68 |
| Corporate Officer/Principal | 37 |
| Chairman | 22 |
| President | 15 |
| Undergraduate Degree | 13 |
Most connected contacts
| Insiders | |
|---|---|
| Curt LaBelle | 31 |
| Hubert Birner | 27 |
| Robert Radie | 18 |
| Lyle A. Hohnke | 17 |
| Susan Stewart | 15 |
| Jonathan Lloyd Jones | 14 |
| Hans Mueller | 12 |
| Alison O'Neill | 10 |
| Nicholas C. Nicolaides | 10 |
| Matthew A. Gonda | 10 |
| Douglas B. Jacoby | 7 |
| E. Michael Egan | 6 |
| Amy E. Bock | 6 |
| Abdellah Sentissi | 5 |
- Stock Market
- Insiders
- Diana M. Hablitz
- Company connections
